Rajiv P. Sharma - Publications

Psychiatry University of Illinois at Chicago, Chicago, IL, United States 
psychosis, epigenetics

81 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Krishnan HR, Vallerini GP, Gavin HE, Guizzetti M, Rizavi HS, Gavin DP, Sharma RP. Effects of alcohol and PARP inhibition on RNA ribosomal engagement in cortical excitatory neurons. Frontiers in Molecular Neuroscience. 16: 1125160. PMID 37113267 DOI: 10.3389/fnmol.2023.1125160  0.629
2022 Rizavi HS, Chase KA, Liu C, Gavin H, Rosen C, Xia C, Guidotti A, Sharma RP. Differential H3K9me2 heterochromatin levels and concordant mRNA expression in postmortem brain tissue of individuals with schizophrenia, bipolar, and controls. Frontiers in Psychiatry. 13: 1006109. PMID 36386965 DOI: 10.3389/fpsyt.2022.1006109  0.711
2021 Melbourne JK, Rosen C, Chase KA, Feiner B, Sharma RP. Monocyte Transcriptional Profiling Highlights a Shift in Immune Signatures Over the Course of Illness in Schizophrenia. Frontiers in Psychiatry. 12: 649494. PMID 34054608 DOI: 10.3389/fpsyt.2021.649494  0.672
2021 Rosen C, Tufano M, Humpston CS, Chase KA, Jones N, Abramowitz AC, Franco Chakkalakal A, Sharma RP. The Sensory and Perceptual Scaffolding of Absorption, Inner Speech, and Self in Psychosis. Frontiers in Psychiatry. 12: 649808. PMID 34045979 DOI: 10.3389/fpsyt.2021.649808  0.624
2020 Rosen C, Chase KA, Perona-Garcelán S, Marvin RW, Sharma RP. The psychometric properties of the DAIMON Scale, a translation from Spanish to English: An instrument to measure the relationship with and between voices. Psychosis. 12: 45-56. PMID 32983256 DOI: 10.1080/17522439.2019.1652843  0.641
2020 Vallerini GP, Cheng YH, Chase KA, Sharma RP, Kusumo H, Khakhkhar S, Feinstein DL, Guizzetti M, Gavin DP. Modulation of Poly ADP Ribose Polymerase (PARP) Levels and Activity by Alcohol Binge-Like Drinking in Male Mice. Neuroscience. PMID 32920042 DOI: 10.1016/J.Neuroscience.2020.09.010  0.757
2020 Rosen C, McCarthy-Jones S, Chase KA, Jones N, Luther L, Melbourne JK, Sudhalkar N, Sharma RP. The role of inner speech on the association between childhood adversity and 'hearing voices'. Psychiatry Research. 286: 112866. PMID 32088506 DOI: 10.1016/J.Psychres.2020.112866  0.63
2019 Melbourne JK, Pang Y, Park MR, Sudhalkar N, Rosen C, Sharma RP. Treatment with the antipsychotic risperidone is associated with increased M1-like JAK-STAT1 signature gene expression in PBMCs from participants with psychosis and THP-1 monocytes and macrophages. International Immunopharmacology. 79: 106093. PMID 31863919 DOI: 10.1016/J.Intimp.2019.106093  0.365
2019 Luther L, Rosen C, Cummins JS, Sharma RP. The multidimensional construct of resilience across the psychosis spectrum: Evidence of alterations in people with early and prolonged psychosis. Psychiatric Rehabilitation Journal. PMID 31750682 DOI: 10.1037/Prj0000393  0.327
2019 Chase KA, Feiner B, Ramaker MJ, Hu E, Rosen C, Sharma RP. Examining the effects of the histone methyltransferase inhibitor BIX-01294 on histone modifications and gene expression in both a clinical population and mouse models. Plos One. 14: e0216463. PMID 31185023 DOI: 10.1371/Journal.Pone.0216463  0.742
2019 Feiner B, Chase KA, Melbourne JK, Rosen C, Sharma RP. Risperidone effects on heterochromatin: the role of kinase signaling. Clinical and Experimental Immunology. PMID 30714144 DOI: 10.1111/Cei.13250  0.66
2019 Rosen C, Chase KA, Perona-Garcelán S, Marvin RW, Sharma RP. The psychometric properties of the DAIMON Scale, a translation from Spanish to English: an instrument to measure the relationship with and between voices Psychosis. 12: 45-56. DOI: 10.1080/17522439.2019.1652843  0.592
2018 Chase KA, Melbourne JK, Rosen C, McCarthy-Jones S, Jones N, Feiner BM, Sharma RP. Traumagenics: At the intersect of childhood trauma, immunity and psychosis. Psychiatry Research. 273: 369-377. PMID 30682559 DOI: 10.1016/J.Psychres.2018.12.097  0.697
2018 Sudhalkar N, Rosen C, Melbourne JK, Park MR, Chase KA, Sharma RP. Long Non-Coding RNAs Associated with Heterochromatin Function in Immune Cells in Psychosis. Non-Coding Rna. 4. PMID 30567388 DOI: 10.3390/Ncrna4040043  0.681
2018 Melbourne JK, Rosen C, Feiner B, Pang Y, Sharma RP. The JAK-STAT1 transcriptional signature in peripheral immune cells reveals alterations related to illness duration and acuity in psychosis. Brain, Behavior, and Immunity. PMID 30503835 DOI: 10.1016/J.Bbi.2018.11.317  0.316
2018 Rosen C, McCarthy-Jones S, Chase KA, Humpston CS, Melbourne JK, Kling L, Sharma RP. The tangled roots of inner speech, voices and delusions. Psychiatry Research. 264: 281-289. PMID 29660570 DOI: 10.1016/J.Psychres.2018.04.022  0.639
2018 Rosen C, McCarthy-Jones S, Jones N, Chase KA, Sharma RP. Negative voice-content as a full mediator of a relation between childhood adversity and distress ensuing from hearing voices. Schizophrenia Research. PMID 29580740 DOI: 10.1016/J.Schres.2018.03.030  0.671
2018 Melbourne JK, Rosen C, Feiner B, Sharma RP. C4A mRNA expression in PBMCs predicts the presence and severity of delusions in schizophrenia and bipolar disorder with psychosis. Schizophrenia Research. PMID 29449061 DOI: 10.1016/J.Schres.2018.01.018  0.425
2017 Melbourne JK, Chase KA, Feiner B, Rosen C, Sharma RP. Long non-coding and endogenous retroviral RNA levels are associated with proinflammatory cytokine mRNA expression in peripheral blood cells: Implications for schizophrenia. Psychiatry Research. PMID 28942956 DOI: 10.1016/J.Psychres.2017.09.025  0.698
2017 Melbourne JK, Feiner B, Rosen C, Sharma RP. Targeting the Immune System with Pharmacotherapy in Schizophrenia. Current Treatment Options in Psychiatry. 4: 139-151. PMID 28674674 DOI: 10.1007/S40501-017-0114-0  0.381
2017 Jenkins LM, Bodapati AS, Sharma RP, Rosen C. Working memory predicts presence of auditory verbal hallucinations in schizophrenia and bipolar disorder with psychosis. Journal of Clinical and Experimental Neuropsychology. 1-11. PMID 28562181 DOI: 10.1080/13803395.2017.1321106  0.389
2017 Rosen C, Jones N, Longden E, Chase KA, Shattell M, Melbourne JK, Keedy SK, Sharma RP. Exploring the Intersections of Trauma, Structural Adversity, and Psychosis among a Primarily African-American Sample: A Mixed-Methods Analysis. Frontiers in Psychiatry. 8: 57. PMID 28469582 DOI: 10.3389/Fpsyt.2017.00057  0.665
2017 Rosen C, Jones N, Chase KA, Melbourne JK, Grossman LS, Sharma RP. Immersion in altered experience: An investigation of the relationship between absorption and psychopathology. Consciousness and Cognition. 49: 215-226. PMID 28219788 DOI: 10.1016/J.Concog.2017.01.015  0.681
2017 Rosen C, Jones N, Chase K, Sharma R. 181. The Phenomenological Construct of Self, Voices, and Other Extreme States Schizophrenia Bulletin. 43: S96-S97. DOI: 10.1093/Schbul/Sbx021.259  0.651
2016 Rosen C, Jones N, Chase KA, Gin H, Grossman LS, Sharma RP. The intrasubjectivity of self, voices and delusions: A phenomenological analysis. Psychosis. 8: 357-368. PMID 27829870 DOI: 10.1080/17522439.2016.1162839  0.667
2016 Sharma RP, Rosen C, Melbourne JK, Feiner B, Chase KA. Activated Phosphorylated STAT1 Levels as a Biologically Relevant Immune Signal in Schizophrenia. Neuroimmunomodulation. PMID 27820940 DOI: 10.1159/000450581  0.662
2016 Chase KA, Feiner B, Rosen C, Gavin DP, Sharma RP. Characterization of peripheral cannabinoid receptor expression and clinical correlates in schizophrenia. Psychiatry Research. 245: 346-353. PMID 27591408 DOI: 10.1016/J.Psychres.2016.08.055  0.793
2016 Gavin DP, Kusumo H, Sharma RP, Guizzetti M. Ethanol-induced changes in poly (ADP ribose) polymerase and neuronal developmental gene expression. Neuropharmacology. PMID 27497606 DOI: 10.1016/J.Neuropharm.2016.08.001  0.694
2016 Rosen C, Chase KA, Jones N, Grossman LS, Gin H, Sharma RP. Listening to Schneiderian Voices: A Novel Phenomenological Analysis. Psychopathology. PMID 27304081 DOI: 10.1159/000446546  0.629
2016 Chase KA, Cone JJ, Rosen C, Sharma RP. The value of interleukin 6 as a peripheral diagnostic marker in schizophrenia. Bmc Psychiatry. 16: 152. PMID 27206977 DOI: 10.1186/S12888-016-0866-X  0.671
2016 Rosen C, Jones N, Chase KA, Gin H, Grossman LS, Sharma RP. The intrasubjectivity of self, voices and delusions: A phenomenological analysis Psychosis. 1-12. DOI: 10.1080/17522439.2016.1162839  0.64
2015 Rosen C, Jones N, Chase KA, Grossman LS, Gin H, Sharma RP. Self, Voices and Embodiment: A Phenomenological Analysis. Journal of Schizophrenia Research. 2. PMID 27099869  0.598
2015 Sharma RP, Feiner B, Chase KA. Histone H3 phosphorylation is upregulated in PBMCs of schizophrenia patients in comparison to healthy controls. Schizophrenia Research. PMID 26476617 DOI: 10.1016/J.Schres.2015.09.030  0.697
2015 Gavin DP, Kusumo H, Sharma RP, Guizzetti M, Guidotti A, Pandey SC. Gadd45b and N-methyl-D-aspartate induced DNA demethylation in postmitotic neurons. Epigenomics. 7: 567-79. PMID 26111030 DOI: 10.2217/Epi.15.12  0.678
2015 Chase KA, Rosen C, Rubin LH, Feiner B, Bodapati AS, Gin H, Hu E, Sharma RP. Evidence of a sex-dependent restrictive epigenome in schizophrenia. Journal of Psychiatric Research. 65: 87-94. PMID 25935252 DOI: 10.1016/J.Jpsychires.2015.04.005  0.708
2015 Chase KA, Rosen C, Gin H, Bjorkquist O, Feiner B, Marvin R, Conrin S, Sharma RP. Metabolic and inflammatory genes in schizophrenia. Psychiatry Research. 225: 208-11. PMID 25433960 DOI: 10.1016/J.Psychres.2014.11.007  0.684
2015 Gavin DP, Kusumo H, Sharma RP, Guizzetti M, Guidotti A, Pandey SC. Gadd45b and N-methyl-d-aspartate induced DNA demethylation in postmitotic neurons Epigenomics. 7: 567-579. DOI: 10.2217/epi.15.12  0.638
2015 Bodapati A, Herbener E, Olsen E, Bjorkquist O, Chase K, Rosen C, Sharma R. A-41Social and Nonsocial Attention in Schizophrenia Archives of Clinical Neuropsychology. 30: 501.1-501. DOI: 10.1093/arclin/acv047.41  0.644
2014 Guidotti A, Auta J, Davis JM, Dong E, Gavin DP, Grayson DR, Sharma RP, Smith RC, Tueting P, Zhubi A. Toward the identification of peripheral epigenetic biomarkers of schizophrenia. Journal of Neurogenetics. 28: 41-52. PMID 24702539 DOI: 10.3109/01677063.2014.892485  0.723
2013 Chase K, Sharma RP. Epigenetic developmental programs and adipogenesis: implications for psychotropic induced obesity. Epigenetics : Official Journal of the Dna Methylation Society. 8: 1133-40. PMID 23959141 DOI: 10.4161/Epi.26027  0.632
2013 Gavin DP, Chase KA, Sharma RP. Active DNA demethylation in post-mitotic neurons: a reason for optimism. Neuropharmacology. 75: 233-45. PMID 23958448 DOI: 10.1016/J.Neuropharm.2013.07.036  0.779
2013 Chase KA, Gavin DP, Guidotti A, Sharma RP. Histone methylation at H3K9: evidence for a restrictive epigenome in schizophrenia. Schizophrenia Research. 149: 15-20. PMID 23815974 DOI: 10.1016/J.Schres.2013.06.021  0.81
2013 Chase KA, Sharma RP. Nicotine induces chromatin remodelling through decreases in the methyltransferases GLP, G9a, Setdb1 and levels of H3K9me2. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 1129-38. PMID 23067581 DOI: 10.1017/S1461145712001101  0.671
2012 Sharma RP. Blood chromatin as a biosensor of the epigenetic milieu: a tool for studies in living psychiatric patients. Epigenomics. 4: 551-9. PMID 23130836 DOI: 10.2217/Epi.12.46  0.332
2012 Sharma RP, Chase KA. Increasing neuronal 'stemness': chromatin relaxation and the expression of reprogramming genes in post-mitotic neurons. Medical Hypotheses. 78: 553-4. PMID 22326495 DOI: 10.1016/J.Mehy.2011.12.018  0.65
2012 Sharma RP, Gavin DP, Chase KA. Heterochromatin as an incubator for pathology and treatment non-response: implication for neuropsychiatric illness. The Pharmacogenomics Journal. 12: 361-7. PMID 22249356 DOI: 10.1038/Tpj.2011.64  0.789
2012 Gavin DP, Sharma RP, Chase KA, Matrisciano F, Dong E, Guidotti A. Growth arrest and DNA-damage-inducible, beta (GADD45b)-mediated DNA demethylation in major psychosis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 531-42. PMID 22048458 DOI: 10.1038/Npp.2011.221  0.785
2012 Gavin DP, Sharma RP, Chase KA, Matrisciano F, Dong E, Guidotti A. Erratum: Growth Arrest and DNA-Damage-Inducible, Beta (GADD45b)-Mediated DNA Demethylation in Major Psychosis Neuropsychopharmacology. 37: 2173-2173. DOI: 10.1038/Npp.2012.55  0.752
2011 Gavin DP, Chase KA, Sharma RP. Enhancement of psychotherapy using epigenetic modulating drugs. Medical Hypotheses. 77: 121-4. PMID 21504840 DOI: 10.1016/J.Mehy.2011.03.042  0.773
2011 Guidotti A, Auta J, Chen Y, Davis JM, Dong E, Gavin DP, Grayson DR, Matrisciano F, Pinna G, Satta R, Sharma RP, Tremolizzo L, Tueting P. Epigenetic GABAergic targets in schizophrenia and bipolar disorder. Neuropharmacology. 60: 1007-16. PMID 21074545 DOI: 10.1016/J.Neuropharm.2010.10.021  0.737
2010 Sharma RP, Gavin DP, Grayson DR. CpG methylation in neurons: message, memory, or mask? Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 2009-20. PMID 20631690 DOI: 10.1038/Npp.2010.85  0.695
2010 Grayson DR, Kundakovic M, Sharma RP. Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders? Molecular Pharmacology. 77: 126-35. PMID 19917878 DOI: 10.1124/Mol.109.061333  0.421
2010 Gavin DP, Sharma RP. Histone modifications, DNA methylation, and schizophrenia. Neuroscience and Biobehavioral Reviews. 34: 882-8. PMID 19879893 DOI: 10.1016/J.Neubiorev.2009.10.010  0.746
2009 Gavin DP, Sharma RP. Chromatin from peripheral blood mononuclear cells as biomarkers for epigenetic abnormalities in schizophrenia. Cardiovascular Psychiatry and Neurology. 2009: 409562. PMID 20029620 DOI: 10.1155/2009/409562  0.739
2009 Gavin DP, Rosen C, Chase K, Grayson DR, Tun N, Sharma RP. Dimethylated lysine 9 of histone 3 is elevated in schizophrenia and exhibits a divergent response to histone deacetylase inhibitors in lymphocyte cultures. Journal of Psychiatry & Neuroscience : Jpn. 34: 232-7. PMID 19448855  0.801
2009 Gavin DP, Kartan S, Chase K, Jayaraman S, Sharma RP. Histone deacetylase inhibitors and candidate gene expression: An in vivo and in vitro approach to studying chromatin remodeling in a clinical population. Journal of Psychiatric Research. 43: 870-6. PMID 19187942 DOI: 10.1016/J.Jpsychires.2008.12.006  0.802
2009 Imbesi M, Yildiz S, Dirim Arslan A, Sharma R, Manev H, Uz T. Dopamine receptor-mediated regulation of neuronal "clock" gene expression. Neuroscience. 158: 537-44. PMID 19017537 DOI: 10.1016/J.Neuroscience.2008.10.044  0.303
2009 Imbesi M, Arslan AD, Yildiz S, Sharma R, Gavin D, Tun N, Manev H, Uz T. The melatonin receptor MT1 is required for the differential regulatory actions of melatonin on neuronal 'clock' gene expression in striatal neurons in vitro. Journal of Pineal Research. 46: 87-94. PMID 18798788 DOI: 10.1111/J.1600-079X.2008.00634.X  0.669
2008 Gavin DP, Kartan S, Chase K, Grayson DR, Sharma RP. Reduced baseline acetylated histone 3 levels, and a blunted response to HDAC inhibition in lymphocyte cultures from schizophrenia subjects. Schizophrenia Research. 103: 330-2. PMID 18539439 DOI: 10.1016/J.Schres.2008.04.026  0.813
2008 Sharma RP, Tun N, Grayson DR. Depolarization induces downregulation of DNMT1 and DNMT3a in primary cortical cultures. Epigenetics : Official Journal of the Dna Methylation Society. 3: 74-80. PMID 18536530 DOI: 10.4161/Epi.3.2.6103  0.359
2008 Sharma RP, Grayson DR, Gavin DP. Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: analysis of the National Brain Databank microarray collection. Schizophrenia Research. 98: 111-7. PMID 17961987 DOI: 10.1016/J.Schres.2007.09.020  0.743
2006 Sharma RP, Rosen C, Kartan S, Guidotti A, Costa E, Grayson DR, Chase K. Valproic acid and chromatin remodeling in schizophrenia and bipolar disorder: preliminary results from a clinical population. Schizophrenia Research. 88: 227-31. PMID 16996718 DOI: 10.1016/J.Schres.2006.07.015  0.707
2006 Grayson DR, Chen Y, Costa E, Dong E, Guidotti A, Kundakovic M, Sharma RP. The human reelin gene: transcription factors (+), repressors (-) and the methylation switch (+/-) in schizophrenia. Pharmacology & Therapeutics. 111: 272-86. PMID 16574235 DOI: 10.1016/J.Pharmthera.2005.01.007  0.456
2005 Grayson DR, Jia X, Chen Y, Sharma RP, Mitchell CP, Guidotti A, Costa E. Reelin promoter hypermethylation in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 102: 9341-6. PMID 15961543 DOI: 10.1073/Pnas.0503736102  0.441
2005 Noh JS, Sharma RP, Veldic M, Salvacion AA, Jia X, Chen Y, Costa E, Guidotti A, Grayson DR. DNA methyltransferase 1 regulates reelin mRNA expression in mouse primary cortical cultures. Proceedings of the National Academy of Sciences of the United States of America. 102: 1749-54. PMID 15671176 DOI: 10.1073/Pnas.0409648102  0.411
2005 Sharma RP. Schizophrenia, epigenetics and ligand-activated nuclear receptors: a framework for chromatin therapeutics. Schizophrenia Research. 72: 79-90. PMID 15560954 DOI: 10.1016/J.Schres.2004.03.001  0.443
2002 Tremolizzo L, Carboni G, Ruzicka WB, Mitchell CP, Sugaya I, Tueting P, Sharma R, Grayson DR, Costa E, Guidotti A. An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proceedings of the National Academy of Sciences of the United States of America. 99: 17095-100. PMID 12481028 DOI: 10.1073/Pnas.262658999  0.43
2002 Chen Y, Sharma RP, Costa RH, Costa E, Grayson DR. On the epigenetic regulation of the human reelin promoter. Nucleic Acids Research. 30: 2930-9. PMID 12087179 DOI: 10.1093/Nar/Gkf401  0.402
2001 Sharma RP, Martis B, Rosen C, Jonalagadda J, Nemeroff CB, Bissette G. CSF thyrotropin-releasing hormone concentrations differ in patients with schizoaffective disorder from patients with schizophrenia or mood disorders. Journal of Psychiatric Research. 35: 287-91. PMID 11591431 DOI: 10.1016/S0022-3956(01)00033-4  0.364
2001 Janicak PG, Keck PE, Davis JM, Kasckow JW, Tugrul K, Dowd SM, Strong J, Sharma RP, Strakowski SM. A double-blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorder. Journal of Clinical Psychopharmacology. 21: 360-8. PMID 11476119 DOI: 10.1097/00004714-200108000-00002  0.305
2000 Guidotti A, Auta J, Davis JM, Di-Giorgi-Gerevini V, Dwivedi Y, Grayson DR, Impagnatiello F, Pandey G, Pesold C, Sharma R, Uzunov D, Costa E, DiGiorgi Gerevini V. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Archives of General Psychiatry. 57: 1061-9. PMID 11074872 DOI: 10.1001/Archpsyc.57.11.1061  0.423
1999 Sharma RP, Singh V, Janicak PG, Javaid JI, Pandey GN. The prolactin response to fenfluramine in schizophrenia is associated with negative symptoms. Schizophrenia Research. 39: 85-9. PMID 10480671 DOI: 10.1016/S0920-9964(99)00014-6  0.37
1998 Impagnatiello F, Guidotti AR, Pesold C, Dwivedi Y, Caruncho H, Pisu MG, Uzunov DP, Smalheiser NR, Davis JM, Pandey GN, Pappas GD, Tueting P, Sharma RP, Costa E. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 95: 15718-23. PMID 9861036 DOI: 10.1073/Pnas.95.26.15718  0.391
1998 Sharma RP, Javaid JI, Davis JM, Janicak PG. Pretreatment plasma homovanillic acid in schizophrenia and schizoaffective disorder: the influence of demographic variables and the inpatient drug-free period. Biological Psychiatry. 44: 488-92. PMID 9777181 DOI: 10.1016/S0006-3223(97)00451-4  0.338
1997 Sharma RP, Janicak PG, Bissette G, Nemeroff CB. CSF neurotensin concentrations and antipsychotic treatment in schizophrenia and schizoaffective disorder. The American Journal of Psychiatry. 154: 1019-21. PMID 9210757 DOI: 10.1176/Ajp.154.7.1019  0.38
1997 Sharma RP, Shapiro LE, Kamath SK, Soll EA, Watanabe MD, Davis JM. Acute dietary tryptophan depletion: effects on schizophrenic positive and negative symptoms. Neuropsychobiology. 35: 5-10. PMID 9018017 DOI: 10.1159/000119323  0.369
1996 Sharma R, Dowd S, Davis J, Janicak P. Age of illness onset and the inpatient drug washout Biological Psychiatry. 39: 553. DOI: 10.1016/0006-3223(96)84129-1  0.342
1995 Sharma RP, Bissette G, Janicak PG, Davis JM, Nemeroff CB. Elevation of CSF somatostatin concentrations in mania. The American Journal of Psychiatry. 152: 1807-9. PMID 8526251 DOI: 10.1176/Ajp.152.12.1807  0.337
1995 Sharma RP, Faull K, Javaid JI, Davis JM. Cerebrospinal fluid levels of phenylacetic acid in mental illness: behavioral associations and response to neuroleptic treatment. Acta Psychiatrica Scandinavica. 91: 293-8. PMID 7639084 DOI: 10.1111/J.1600-0447.1995.Tb09785.X  0.361
1994 Sharma RP, Bissette G, Janicak P, Davis JM, Nemeroff CB. Cerebrospinal fluid somatostatin concentrations in schizophrenia and schizoaffective disorder: the effects of antipsychotic treatment. Schizophrenia Research. 13: 173-7. PMID 7986775 DOI: 10.1016/0920-9964(94)90099-X  0.33
1991 Sharma RP, Javaid JI, Pandey GN, Janicak PG, Davis JM. Behavioral and biochemical effects of methylphenidate in schizophrenic and nonschizophrenic patients. Biological Psychiatry. 30: 459-66. PMID 1657221 DOI: 10.1016/0006-3223(91)90307-8  0.317
Show low-probability matches.